Cutaneous T-cell lymphoma: pathogenesis and treatment.
Cutaneous T-cell lymphoma (CTCL) is a malignancy of a distinctive subset of T-helper cells designated "cutaneous T cells" because of their central role in the normal functioning of the skin immune system. Guided by selective adhesion molecules, activated/memory T cells of the skin immune system normally circulate among the skin, lymph nodes, and peripheral blood. Thus, a better understanding of the skin immune system, which normally functions to provide immunosurveillance against cutaneous pathogens and other insults, has led to a better understanding of the clinical spectrum, pathogenesis, staging, and management of CTCL. This article describes the major subtypes of CTCL and provides an update on the pathogenesis and treatment of this lymphoma.
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
M
M
Girardi
R L
RL
Edelson
D005544:Forecasting; D006801:Humans; D016399:Lymphoma, T-Cell / Q000145:classification / Q000209:etiology* / Q000276:immunology / Q000628:therapy*; D009367:Neoplasm Staging; D012867:Skin / Q000276:immunology; D012878:Skin Neoplasms / Q000145:classification / Q000209:etiology* / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology